321 related articles for article (PubMed ID: 35318571)
1. Antiplatelet therapy associated with lower prevalence of advanced liver fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Thongtan T; Deb A; Vutthikraivit W; Laoveeravat P; Mingbunjerdsuk T; Islam S; Islam E
Indian J Gastroenterol; 2022 Apr; 41(2):119-126. PubMed ID: 35318571
[TBL] [Abstract][Full Text] [Related]
2. The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis-A Systematic Review, Meta-Analysis and Meta-Regression.
Gudan A; Jamioł-Milc D; Hawryłkowicz V; Skonieczna-Żydecka K; Stachowska E
Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558421
[TBL] [Abstract][Full Text] [Related]
3. Effect of Coffee Consumption on Non-Alcoholic Fatty Liver Disease Incidence, Prevalence and Risk of Significant Liver Fibrosis: Systematic Review with Meta-Analysis of Observational Studies.
Ebadi M; Ip S; Bhanji RA; Montano-Loza AJ
Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578919
[TBL] [Abstract][Full Text] [Related]
4. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis.
Quek J; Chan KE; Wong ZY; Tan C; Tan B; Lim WH; Tan DJH; Tang ASP; Tay P; Xiao J; Yong JN; Zeng RW; Chew NWS; Nah B; Kulkarni A; Siddiqui MS; Dan YY; Wong VW; Sanyal AJ; Noureddin M; Muthiah M; Ng CH
Lancet Gastroenterol Hepatol; 2023 Jan; 8(1):20-30. PubMed ID: 36400097
[TBL] [Abstract][Full Text] [Related]
5. Hyperuricemia is not associated with severity of liver fibrosis in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Jaruvongvanich V; Ahuja W; Wijarnpreecha K; Ungprasert P
Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):694-697. PubMed ID: 28252464
[TBL] [Abstract][Full Text] [Related]
6. Bidirectional association between non-alcoholic fatty liver disease and fatty pancreas: a systematic review and meta-analysis.
Wongtrakul W; Untaaveesup S; Pausawadi N; Charatcharoenwitthaya P
Eur J Gastroenterol Hepatol; 2023 Oct; 35(10):1107-1116. PubMed ID: 37665612
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular and extrahepatic cancers in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Thomas JA; Kendall BJ; Dalais C; Macdonald GA; Thrift AP
Eur J Cancer; 2022 Sep; 173():250-262. PubMed ID: 35944373
[TBL] [Abstract][Full Text] [Related]
8. Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis.
Rich NE; Oji S; Mufti AR; Browning JD; Parikh ND; Odewole M; Mayo H; Singal AG
Clin Gastroenterol Hepatol; 2018 Feb; 16(2):198-210.e2. PubMed ID: 28970148
[TBL] [Abstract][Full Text] [Related]
9. Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but a Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis.
Balakrishnan M; Patel P; Dunn-Valadez S; Dao C; Khan V; Ali H; El-Serag L; Hernaez R; Sisson A; Thrift AP; Liu Y; El-Serag HB; Kanwal F
Clin Gastroenterol Hepatol; 2021 Jan; 19(1):61-71.e15. PubMed ID: 32360810
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and Characteristics of Nonalcoholic Fatty Liver Disease and Fibrosis in People Living With HIV Monoinfection: A Systematic Review and Meta-analysis.
Kalligeros M; Vassilopoulos A; Shehadeh F; Vassilopoulos S; Lazaridou I; Mylonakis E; Promrat K; Wands JR
Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1708-1722. PubMed ID: 36642292
[TBL] [Abstract][Full Text] [Related]
11. Modest alcohol consumption and risk of advanced liver fibrosis in nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Wijarnpreecha K; Aby ES; Panjawatanan P; Lapumnuaypol K; Cheungpasitporn W; Lukens FJ; Harnois DM; Ungprasert P
Ann Gastroenterol; 2021; 34(4):568-574. PubMed ID: 34276197
[TBL] [Abstract][Full Text] [Related]
12. Daily Aspirin Use Associated With Reduced Risk For Fibrosis Progression In Patients With Nonalcoholic Fatty Liver Disease.
Simon TG; Henson J; Osganian S; Masia R; Chan AT; Chung RT; Corey KE
Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2776-2784.e4. PubMed ID: 31077838
[TBL] [Abstract][Full Text] [Related]
13. Physical activity and diet quality in relation to non-alcoholic fatty liver disease: A cross-sectional study in a representative sample of U.S. adults using NHANES 2017-2018.
Heredia NI; Zhang X; Balakrishnan M; Daniel CR; Hwang JP; McNeill LH; Thrift AP
Prev Med; 2022 Jan; 154():106903. PubMed ID: 34861339
[TBL] [Abstract][Full Text] [Related]
14. The effect of coffee consumption on the non-alcoholic fatty liver disease and liver fibrosis: A meta-analysis of 11 epidemiological studies.
Hayat U; Siddiqui AA; Okut H; Afroz S; Tasleem S; Haris A
Ann Hepatol; 2021; 20():100254. PubMed ID: 32920163
[TBL] [Abstract][Full Text] [Related]
15. Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis.
En Li Cho E; Ang CZ; Quek J; Fu CE; Lim LKE; Heng ZEQ; Tan DJH; Lim WH; Yong JN; Zeng R; Chee D; Nah B; Lesmana CRA; Bwa AH; Win KM; Faulkner C; Aboona MB; Lim MC; Syn N; Kulkarni AV; Suzuki H; Takahashi H; Tamaki N; Wijarnpreecha K; Huang DQ; Muthiah M; Ng CH; Loomba R
Gut; 2023 Nov; 72(11):2138-2148. PubMed ID: 37491159
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of portal vein thrombosis in non-alcoholic fatty liver disease: a meta-analysis of observational studies.
Stupia R; Lombardi R; Cattazzo F; Zoncapè M; Mantovani A; De Marco L; Mantovani A; Fracanzani AL; Sacerdoti D; Dalbeni A
J Thromb Thrombolysis; 2024 Feb; 57(2):330-336. PubMed ID: 38066387
[TBL] [Abstract][Full Text] [Related]
17. Systematic review with meta-analysis: de novo non-alcoholic fatty liver disease in liver-transplanted patients.
Losurdo G; Castellaneta A; Rendina M; Carparelli S; Leandro G; Di Leo A
Aliment Pharmacol Ther; 2018 Mar; 47(6):704-714. PubMed ID: 29359341
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of statins in treatment and development of non-alcoholic fatty liver disease and steatohepatitis: A systematic review and meta-analysis.
Fatima K; Moeed A; Waqar E; Atif AR; Kamran A; Rizvi H; Suri NF; Haider H; Shuja SH; Khalid M; Minhas AMK
Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101816. PubMed ID: 34607067
[TBL] [Abstract][Full Text] [Related]
19. Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis.
Vali Y; Lee J; Boursier J; Spijker R; Löffler J; Verheij J; Brosnan MJ; Böcskei Z; Anstee QM; Bossuyt PM; Zafarmand MH;
J Hepatol; 2020 Aug; 73(2):252-262. PubMed ID: 32275982
[TBL] [Abstract][Full Text] [Related]
20. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Ye Q; Zou B; Yeo YH; Li J; Huang DQ; Wu Y; Yang H; Liu C; Kam LY; Tan XXE; Chien N; Trinh S; Henry L; Stave CD; Hosaka T; Cheung RC; Nguyen MH
Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):739-752. PubMed ID: 32413340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
